Most Recent Articles by Tori Rodriguez, MA, LPC
Recent studies have focused on the role of calcitonin gene-related peptides in cluster headache.
There is significant evidence that opioids are not the right treatment of choice for migraine in the emergency department.
The results highlight the importance of evaluating and monitoring cognitive function in individuals with recent critical illness or major infections, especially if they are already at risk for dementia.
The new guidelines will facilitate the design and development of clinical trials to test new therapies to minimize the burden of neurologic disability produced by neurosarcoidosis.
There are considerations for treating these seizures as part of the overall goals of palliative care, which include the family's experience.
More Articles by Tori Rodriguez, MA, LPC
Neurology Advisor Articles
- Surgical, Nonsurgical Treatments for Chronic Migraine: Evidence and Relevancy
- Neurofilament Light Biomarkers Identify Alzheimer Disease Risk in Down Syndrome
- Myoclonic-Atonic Seizures and Lennox-Gastaut Syndrome Present With Overlapping Features, Difficulty in Diagnosis
- Tap Water in Neti Pot Linked to Brain Infection, Death From Balamuthia mandrillaris
- Rituximab Effects in Neuromyelitis Optica Spectrum Disorders
- Study Identifies Early-Onset Motor Behaviors in DES-Triggered Seizures
- Autoimmune Diseases Increase Hippocampal Sclerosis Risk in Nonagenarians
- Smaller Heads Related to Opioid-Related Neonatal Abstinence Syndrome
- Hearing Loss in Older Adults Linked to Depression, Dementia Among Other Comorbidities
- Bumetanide May Benefit Children With Autism Spectrum Disorder